Gensia Treatment OKd

Gensia Laboratories Ltd., an Irvine maker and marketer of drug products, said Tuesday that it received federal approval for a new drug application that helps treat lung cancer.

Gensia received approval for an abbreviated new drug application for etoposide injection in polymer vials. Etoposide is an agent used in the treatment of patients with small-cell lung cancer and refractory testicular tumors.

“Etoposide is the second oncology product that we will supply in unique polymer packaging following the successful introduction of doxorubicin in this packaging format,” said Patrick D. Walsh, Gensia’s president.

Gensia is a wholly owned subsidiary of Gensia Inc., a San Diego medical research company.